48,466
edits
Difference between revisions of "Porocarcinoma"
Jump to navigation
Jump to search
no edit summary
(create) |
|||
| Line 3: | Line 3: | ||
==General== | ==General== | ||
*Malignant counterpart of ''[[poroma]]''. | *Malignant counterpart of ''[[poroma]]''. | ||
*Very rare ~ most papers are case reports.<ref name=pmid25515648>{{Cite journal | last1 = Riera-Leal | first1 = L. | last2 = Guevara-Gutiérrez | first2 = E. | last3 = Barrientos-García | first3 = JG. | last4 = Madrigal-Kasem | first4 = R. | last5 = Briseño-Rodríguez | first5 = G. | last6 = Tlacuilo-Parra | first6 = A. | title = Eccrine porocarcinoma: epidemiologic and histopathologic characteristics. | journal = Int J Dermatol | volume = 54 | issue = 5 | pages = 580-6 | month = | year = 2015 | doi = 10.1111/ijd.12714 | PMID = 25515648 }}</ref> | |||
Clinical - based on meta-analysis of 453 cases: | Clinical - based on meta-analysis of 453 cases: | ||
*No predominance males versus females. | *No predominance males versus females. | ||
*Aggressive behaviour >30% of cases have metastases at presentation - typically to lymph nodes. | |||
Treatment: | |||
*Surgery, | |||
==Gross== | ==Gross== | ||